United Imaging – New FDA-Cleared Modalities

United Imaging announced FDA clearances for its uMR Ultra and uOmniscan™ systems, timed ahead of the company’s AHRA 2025 showcase. These new modalities represent the company’s effort to expand into more comprehensive imaging portfolios, blending high-performance hardware with integrated AI features.

By positioning itself as a full-suite modality provider, United Imaging is signaling its intent to compete more directly with established giants like Siemens and GE. The FDA clearances give the company momentum heading into trade show season, where vendors increasingly use AHRA and RSNA as launchpads for new technology announcements.